FDFT1-INTS9 Fusion FISH Probe
The FDFT1-INTS9 Fusion FISH Probe is used to confirm a fusion of the FDFT1 and INTS9 genes. The fusion of the FDFT1 and INTS9 genes has been associated with Breast Invasive Carcinoma, and Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FDFT1-INTS9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FDFT1-INTS9-20-AQAQ | 20 (40 μL) | 200 μL |
|
FDFT1 Gene Summary
This gene encodes a membrane-associated enzyme located at a branch point in the mevalonate pathway. The encoded protein is the first specific enzyme in cholesterol biosynthesis, catalyzing the dimerization of two molecules of farnesyl diphosphate in a two-step reaction to form squalene. [provided by RefSeq, Jul 2008]
Gene Name: Farnesyl-diphosphate Farnesyltransferase 1
Chromosome: CHR8: 11660189 -11696818
Locus: 8p23.1
INTS9 Gene Summary
This gene encodes a subunit of the Integrator complex. This protein complex binds the C-terminal domain of RNA polymerase II and likely plays a role in small nuclear RNA processing. The encoded protein has similarities to the subunits of the cleavage and polyadenylation specificity factor complex. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
Gene Name: Integrator Complex Subunit 9
Chromosome: CHR8: 28625174 -28747698
Locus: 8p21.1
Gene Diseases
The FDFT1 INTS9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|